Shares of Richtech Robotics (Nasdaq: RR) plunged 13.5% to $1.99 after the company told investors to discard two full years of financial statements, deepening a credibility crisis for a firm already under a securities class-action lawsuit and a Nasdaq compliance warning.
• The Errors Run Deeper Than One Bad Quarter. The company disclosed that investors should no longer rely on financial statements for fiscal years ended September 2024 and 2025, or related interim quarters, due to errors in how it recorded liabilities for warrants, a standby equity purchase agreement, and certain restricted stock awards.
Richtech had previously reported a material weakness in internal controls as of September 2025 — it now expects to report an additional material weakness related to financial instruments and concedes the earlier one was never actually fixed. For shareholders, unreliable numbers covering essentially the company's entire public life as a Nasdaq-listed stock make fundamental analysis nearly impossible.
• The Company Claims Cash Won't Change, but Trust Already Has. Richtech says the restatement will primarily involve non-cash accounting adjustments and does not currently expect changes to its cash position or operating cash flows.
The balance sheet last showed $271.8 million in cash after aggressive equity raises. But the reassurance rings hollow: the company is still evaluating other potential errors that could prove material. Open-ended language like that gives the market no floor to price in.
• A Pattern of Governance Red Flags Is Compounding. This restatement lands on top of a March 2026 auditor switch — the company terminated Bush & Associates CPA and engaged CBIZ CPAs — and a securities class-action lawsuit filed after Hunterbrook Media reported Microsoft denied a commercial partnership with Richtech, sending shares down over 20% in January.
Richtech also failed to timely file its March 2026 quarterly report, triggering a Nasdaq noncompliance notice with a July 21 deadline to submit a remediation plan.
• The Valuation Still Looks Disconnected from Revenue. Trailing twelve-month revenue is just $4.93 million , yet even after today's drop, the market capitalization sits near $500 million — roughly a 100x revenue multiple for a company that can't vouch for its own books. Shares have traded between $7.43 and $1.71 over the past 52 weeks , and the restatement overhang could push a test of the low. Until amended filings land and an auditor signs off, investors are flying completely blind.